|
1
|
Emory TS, Sobin LH, Lukes L, Lee DH and
O’Leary TJ: Prognosis of gastrointestinal smooth-muscle (stromal)
tumours: dependence on anatomic site. Am J Surg Pathol. 23:82–87.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumours - definition, clinical, histological,
immunohistochemical, and molecular genetic features and
differential diagnosis. Virchows Arch. 438:1–12. 2001. View Article : Google Scholar
|
|
3
|
Graadt van Roggen JF, van Velthuysen ML
and Hogendoorn PC: The histopathological differential diagnosis of
gastrointestinal stromal tumours. J Clin Pathol. 54:96–102.
2001.PubMed/NCBI
|
|
4
|
Miettinen M, El-Rifai W, Sobin L and
Lasota J: Evaluation of malignancy and prognosis of
gastrointestinal stromal tumours: a review. Hum Pathol. 33:478–483.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong DW, Lupton SC, Bhatt L, Gross L,
Tanière P, Peake DR, Spooner D and Geh JI: Use of imatinib mesylate
in gastrointestinal stromal tumours: Pan-Birmingham Cancer Network
experience. Clin Oncol (R Coll Radiol). 20:517–522. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Versaci A, Macrì A, Ieni A, Terranova M,
Leonello G, Saladino E, Speciale G and Famulari C: Gastrointestinal
stromal tumour: our experience. Chir Ital. 61:161–169. 2009.(In
Italian).
|
|
7
|
Maheshwari V, Alam K, Varshney M, Jain A,
Asif Siddiqui F and Bhargava S: Fine-needle aspiration diagnosis of
GIST: a diagnostic dilemma. Diagn Cytopathol. 40:834–838. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chan JK: Mesenchymal tumours of the
gastrointestinal tract: a paradise for acronyms (STUMP, GIST, GANT,
and now GIPACT), implication of c-kit in genesis, and yet another
of the many emerging roles of the interstitial cell of Cajal in the
pathogenesis of gastrointestinal diseases? Adv Anat Pathol.
6:19–40. 1999.
|
|
9
|
Sircar K, Hewlett BR, Huizinga JD,
Chorneyko K, Berezin I and Riddel RH: Interstitial cells of Cajal
as precursors of gastrointestinal stromal tumours. Am J Surg
Pathol. 23:377–389. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lerma E, Oliva E, Tugués D and Prat J:
Stromal tumours of the gastrointestinal tract: a
clinicopathological and ploidy analysis of 33 cases. Virchows Arch.
424:19–24. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mehta RM, Sudheer VO, John AK, Nandakumar
RR, Dhar PS, Sudhindran S and Balakrishnan V: Spontaneous rupture
of giant gastric stromal tumor into gastric lumen. World J Surg
Oncol. 3:112005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dematteo RP, Heinrich MC, El-Rifai WM and
Demetri G: Clinical management of gastrointestinal stromal tumours:
before and after STI-571. Hum Pathol. 33:466–477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nilsson B, Bümming P, Meis-Kindblom JM, et
al: Gastrointestinal stromal tumours: the incidence, prevalence,
clinical course, and prognostication in the preimatinib mesylate
era - a population-based study in western Sweden. Cancer.
103:821–829. 2005. View Article : Google Scholar
|
|
14
|
Reid R, O’Dywer P, MacDuff E, et al:
Guidelines for the management of gastrointestinal stromal tumours
(GIST) in Scotland. pp. 53–55. 2009, http://www.pathologyscotland.org/download/sgpg/guidelines/gist.pdf.
Accessed November 13, 2012.
|
|
15
|
Demetri GD, von Mehren M, Blanke CD, et
al: Efficacy and safety of imatinib mesylate in advanced
gastrointestinal stromal tumours. N Engl J Med. 347:472–480. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blay JY, Bonvalot S, Casali P, et al: GIST
consensus meeting panelists: Consensus meeting for the management
of gastrointestinal stromal tumours. Report of the GIST Consensus
Conference of 20–21 March 2004, under the auspices of ESMO. Ann
Oncol. 16:566–578. 2005.PubMed/NCBI
|
|
17
|
Blanke CD, Demetri GD, von Mehren M, et
al: Long-term results from a randomized phase II trial of standard-
versus higher-dose imatinib mesylate for patients with unresectable
or metastatic gastrointestinal stromal tumours expressing KIT. J
Clin Oncol. 26:620–625. 2008. View Article : Google Scholar
|
|
18
|
Nathan NA, Narayan E, Smith MM and Horn
MJ: Cell block cytology. Improved preparation and its efficacy in
diagnostic cytology. Am J Clin Pathol. 114:599–606. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tuccari G, Giuffrè G, Scarfi R, Simone A,
Todaro P and Barresi G: Immunolocalization of lactoferrin in
surgically resected pigmented skin lesions. Eur J Histochem.
49:33–38. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barresi V, Cerasoli S, Paioli G, Vitarelli
E, Giuffrè G, Guiducci G, Tuccari G and Barresi G: Caveolin-1 in
meningiomas: expression and clinico-pathological correlations. Acta
Neuropathol. 112:617–626. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jenssen C and Dietrich CF: Endoscopic
ultrasound guided fine-needle aspiration biopsy and trucut biopsy
in gastroenterology - An overview. Best Pract Res Clin
Gastroenterol. 23:743–759. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Itoi T, Tsuchiya T, Itokawa F, Sofuni A,
Kurihara T, Tsuji S and Ikeuchi N: Histological diagnosis by
Eus-guided fine-needle aspiration biopsy in pancreatic solid masses
without on-site cytopathologist: a single-center experience. Dig
Endosc. 23(Suppl 1): 34–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoshinaga S, Suzuki H, Oda I and Saito Y:
Role of endoscopic ultrasound-guided fine needle aspiration
(EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc.
23(Suppl 1): 29–33. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoda KM, Rodriguez SA and Faigel DO:
EUS-guided sampling of suspected GI stromal tumours. Gastrointest
Endosc. 69:1218–1223. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Panizo-Santes A, Sola I, Vega F, de Alava
E, Lozano MD, Idoate MA and Pardon-Mindán J: Predicting metastatic
risk of gastrointestinal stromal tumours: role of cell
proliferation and cell cycle regulatory proteins. Int J Surg
Pathol. 8:133–144. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fletcher CD, Berman JJ, Corless C, et al:
Diagnosis of gastrointestinal stromal tumours: A consensus
approach. Hum Pathol. 33:459–465. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koon N, Schneider-Stock R, Sarlomo-Rikala
M, Lasota J, Smolkin M, Petroni G, Zaika A, Boltze C, Meyer F,
Andersson L, Knuutila S, Miettinen M and El-Rifai W: Molecular
targets for tumour progression in gastrointestinal stromal tumours.
Gut. 53:235–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim KM, Kang DW, Moon WS, et al
Gastrointestinal stromal tumor committee; The Korean
Gastrointestinal Pathology Study Group: Gastrointestinal stromal
tumours in Koreans: it’s incidence and the clinical, pathologic and
immunohistochemical findings. J Korean Med Sci. 20:977–984.
2005.
|
|
29
|
O’Sullivan B, Deshmukh N, Reynolds G, et
al: Retrospective analysis of GIST in one regional UK reference
centre. Gut. 56(S1): A72007.
|
|
30
|
Ueyama T, Guo KJ, Hashimoto H, Daimaru Y
and Enjoji M: A clinicopathologic and immunohistochemical study of
gastrointestinal stromal tumours. Cancer. 69:947–955. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumours: review on morphology, molecular pathology,
prognosis, and differential diagnosis. Arch Pathol Lab Med.
130:1466–1478. 2006.PubMed/NCBI
|
